Aveanna Healthcare (NASDAQ:AVAH) Insider Patrick Cunningham Sells 12,445 Shares of Stock

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Patrick Cunningham sold 12,445 shares of Aveanna Healthcare stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $97,693.25. Following the completion of the sale, the insider directly owned 293,354 shares in the company, valued at $2,302,828.90. This represents a 4.07% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Aveanna Healthcare Stock Performance

Shares of AVAH stock opened at $8.08 on Friday. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The stock has a 50 day simple moving average of $8.92 and a 200-day simple moving average of $7.49. The company has a market cap of $1.69 billion, a price-to-earnings ratio of 22.44 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a 12-month low of $3.67 and a 12-month high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last posted its quarterly earnings results on Monday, May 22nd. The company reported $0.04 earnings per share for the quarter. The firm had revenue of $450.53 million for the quarter. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%. On average, equities analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently commented on AVAH. Royal Bank Of Canada raised their price objective on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the company a “sector perform” rating in a research note on Friday, October 24th. UBS Group lifted their price target on shares of Aveanna Healthcare from $9.00 to $9.50 and gave the company a “neutral” rating in a research report on Friday, November 7th. Jefferies Financial Group boosted their price target on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research note on Tuesday, October 28th. JPMorgan Chase & Co. upgraded Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their price target for the stock from $6.00 to $10.00 in a report on Thursday, September 18th. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $13.00 price objective on shares of Aveanna Healthcare in a research note on Friday, December 5th. Five analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $10.69.

Key Aveanna Healthcare News

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

Institutional Investors Weigh In On Aveanna Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the stock. Dynamic Technology Lab Private Ltd increased its position in Aveanna Healthcare by 8.9% during the third quarter. Dynamic Technology Lab Private Ltd now owns 14,149 shares of the company’s stock worth $126,000 after buying an additional 1,151 shares in the last quarter. Barclays PLC boosted its stake in shares of Aveanna Healthcare by 0.8% during the third quarter. Barclays PLC now owns 179,359 shares of the company’s stock valued at $1,591,000 after acquiring an additional 1,366 shares during the last quarter. Franklin Resources Inc. increased its position in Aveanna Healthcare by 4.5% during the 3rd quarter. Franklin Resources Inc. now owns 35,630 shares of the company’s stock worth $316,000 after purchasing an additional 1,528 shares in the last quarter. Olympiad Research LP raised its stake in Aveanna Healthcare by 7.5% in the 3rd quarter. Olympiad Research LP now owns 31,621 shares of the company’s stock valued at $280,000 after purchasing an additional 2,200 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in Aveanna Healthcare by 4.0% in the 1st quarter. Rhumbline Advisers now owns 75,581 shares of the company’s stock valued at $410,000 after purchasing an additional 2,918 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Company Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.